Gene · 11004
Papers1,860
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,860
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Chromosomal instability shapes the tumor microenvironment of esophageal adenocarcinoma via a cGAS-chemokine-myeloid axis. | Sci Adv | 2026 | 41811963 | PubTator, text mining | PubMed |
| Identification of Key Genes via Integrated Multi-Omics and Machine Learning Uncovers Tumor Biological Features and Prognostic Biomarkers in Uterine Leiomyosarcoma. | Int J Med Sci | 2026 | 41799759 | PubTator, text mining | PubMed |
| Senescence profiling and biomarker identification in cell product based on adipose tissue-derived mesenchymal stromal cells. | Stem Cells Transl Med | 2026 | 41791726 | PubTator, text mining | PubMed |
| Explainable machine learning framework for the molecular classification of triple negative breast cancer. | Comput Methods Programs Biomed | 2026 | 41775141 | PubTator, text mining | PubMed |
FOXM1 Signaling Network Transcriptionally Upregulates Expression of Proteins Involved in Mitotic Progression to Induce High Proliferation and Chromosomal Instability in Androgen Receptor-Low Triple-Negative Breast Cancer. | Int J Mol Sci | 2026 | 41751958 | PubTator, text mining | PubMed |
| KIF18B Is Essential for Lung Adenocarcinoma Progression Through the E2F Transcriptional Network. | Int J Mol Sci | 2026 | 41751942 | PubTator, text mining | PubMed |
| Low KIF26B Expression Reduces Paclitaxel Resistance and Predicts Good Prognosis in Ovarian Cancer. | Curr Issues Mol Biol | 2026 | 41751488 | PubTator, text mining | PubMed |
| Multi-dimensional integration of gene expression, protein evidence, and serum autoantibodies for diagnostic modeling in esophageal squamous cell carcinoma. | Front Immunol | 2026 | 41743732 | PubTator, text mining | PubMed |
| FOXM1 induces therapy resistance and inhibits apoptosis in a variety of human cancers. | Cell Death Dis | 2026 | 41714589 | PubTator, text mining | PubMed |
| Charting the multilevel molecular response to palbociclib in ER-positive breast cancer. | NAR Cancer | 2026 | 41710088 | PubTator, text mining | PubMed |
| Single-Cell RNAseq Identifies Heterogeneity in Myoblasts From Older Adults With Differences Related to Muscle Mass and Function. | J Cachexia Sarcopenia Muscle | 2026 | 41703779 | PubTator, text mining | PubMed |
| United multi-omics and machine learning refine regulatory T cell-defined hepatocellular carcinoma subtypes. | iScience | 2026 | 41561382 | PubTator, text mining | PubMed |
| FOXM1 regulates platelet-induced anoikis resistance in pancreatic cancer cells. | Cell Commun Signal | 2026 | 41535944 | PubTator, text mining | PubMed |
| Single-cell and machine learning-based analysis of the molecular mechanism of Banxia Xiexin Decoction in the treatment of gastric cancer. | Cytotechnology | 2026 | 41510325 | PubTator, text mining | PubMed |
| An integrated microfluidic system for automated extraction of in vitro transcribed mRNAs via probe-coated magnetic beads. | Lab Chip | 2026 | 41431383 | PubTator, text mining | PubMed |
| An integrated microfluidic system with shear force control for an automatically modified mRNA display technique for screening high-specificity peptide probes. | Lab Chip | 2026 | 41288255 | PubTator, text mining | PubMed |
| Mitochondrial-associated PCD signature defines immune landscape, therapeutic sensitivity, and prognosis in hepatocellular carcinoma. | Discov Oncol | 2025 | 41466155 | PubTator, text mining | PubMed |
| Overexpression of CDC20 Confer a Poorer Prognosis in Bladder Cancer Identified by Gene Co-Expression Network Analysis. | Diagnostics (Basel) | 2025 | 41374402 | PubTator, text mining | PubMed |
| A Machine Learning-Derived Taurine Metabolism Signature Predicts Prognosis and Immune Landscape in Lung Adenocarcinoma via Integrative Single-Cell Analysis. | Mediators Inflamm | 2025 | 41341805 | PubTator, text mining | PubMed |
| Consensus Integration of Multiomics Data With Machine Learning Algorithms Reveals Heterogeneous Molecular Subtypes and Enables Personalized Treatment Strategies for Hepatocellular Carcinoma. | Hum Mutat | 2025 | 41333555 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11004/papers?page=2